How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?

Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy.

Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.

(Image credit: David Morrison/AP)

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

6 TIPS TO ESTABLISHING & MAINTAINING BREASTMILK SUPPLY WITH A NEWBORN

GETTING BACK TO SCHOOL SAFELY